Table 1. Participant demographics.
Subject code | Sex | Age range (years) | Time since stroke (months) | Affected visual hemifield | Training Group |
---|---|---|---|---|---|
CB1 | m | 46–50 | 32 | R | Intact |
CB2 | f | 46–50 | 13 | R | Intact |
CB3 | m | 70–75 | 20 | L | Intact |
CB4 | m | 60–65 | 61 | L | Intact |
CB5 | m | 60–65 | 43 | L | Intact |
CB6 | m | 55–60 | 105 | R | Intact |
CB7 | f | 70–75 | 338 | L | Intact |
CB8 | m | 70–75 | 10 | L | Intact |
CB9 | m | 66–70 | 6 | R | Intact |
CB10 | m | 70–75 | 4 | L | Intact |
CB11 | m | 70–75 | 58 | L | Intact |
CB12 | f | 66–70 | 16 | R | Intact |
CB13 | f | 50–55 | 24 | L | Intact |
CB14 | m | 60–65 | 130 | L | Intact |
CB15 | m | 56–60 | 13 | L | Intact |
CB16 | m | 46–50 | 63 | L | Intact |
CB17 | m | 60–65 | 8 | L | Intact |
CB18 | f | 46–50 | 15 | R | Intact |
CB19 | m | 60–65 | 20 | R | Intact |
CB20 | m | 40–45 | 5 | R | Intact |
CB21 | m | 66–70 | 3 | R | Intact |
CB22 | m | 56–60 | 4 | R | Intact |
CB23 | m | 70–75 | 6 | L | Intact |
CB24 | m | 66–70 | 60 | L | Blind |
CB25 | f | 50–55 | 38 | R | Blind |
CB26 | f | 50–55 | 18 | L | Blind |
CB27 | m | 40–45 | 15 | R | Blind |
CB28 | m | 50–55 | 373 | R | Blind |
CB29 | m | 60–65 | 5 | R | Blind |
CB30 | m | 70–75 | 47 | R | Blind |
CB31 | m | 56–60 | 8 | L | Blind |
CB32 | m | 60–65 | 47 | L | Blind |
CB33 | m | 40–45 | 11 | R | Blind |
CB34 | m | 56–60 | 4 | L | Blind |
CB35 | f | 40–45 | 10 | R | Blind |
CB36 | m | 66–70 | 105 | L | Blind |
CB37 | m | 66–70 | 36 | R | Blind |
CB38 | m | 30–35 | 5 | R | Blind |
CB39 | f | 46–50 | 5 | L | Blind |
CB40 | f | 60–65 | 3 | L | Blind |
CB41 | m | 46–50 | 14 | R | Blind |
CB42 | m | 66–70 | 3 | L | Blind |
CB43 | m | 70–75 | 6 | L | Blind |